Onconetix (ONCO) Inventory Average (2023 - 2026)
Onconetix (ONCO) posted quarterly Inventory Average of $143801.5 for Q1 2026, up 30.88% year-over-year from $109869.5 in Q1 2025, and down 4.61% quarter-over-quarter from $150758.5 in Q4 2025.
Onconetix (ONCO) Inventory Average (2023 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Inventory Average for 4 consecutive years, with $143801.5 the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 30.88% year-over-year to $143801.5; the TTM figure through Mar 2026 stood at $143801.5 (up 30.88% YoY), while the FY2025 annual figure was $107020.0, down 50.01% from the prior year.
- Inventory Average eased to $143801.5 in Q1 2026 per ONCO's latest filing, from $150758.5 in the prior quarter.
- Across five years, Inventory Average topped out at $1.3 million in Q3 2023 and bottomed at $92956.5 in Q4 2024.
- Historically, Inventory Average has averaged $344621.9 across 4 years, with a median of $152314.0 in 2025.
- Annual changes were most pronounced in 2024 — Inventory Average sank 89.57% — and 2025, when it soared 62.18%.
- Onconetix's Inventory Average stood at $891662.0 in 2023, then tumbled by 89.57% to $92956.5 in 2024, then jumped by 62.18% to $150758.5 in 2025, then retreated by 4.61% to $143801.5 in 2026.
- Business Quant data shows ONCO's Inventory Average at $143801.5 in Q1 2026, $150758.5 in Q4 2025, and $152314.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Onconetix | 1.45 Mn | -4.50 Mn | 4,303.00 | 174,045.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 174,045.00 |
| Mar 31, 2026 | 143,801.50 |
| Dec 31, 2025 | 150,758.50 |
| Sep 30, 2025 | 152,314.00 |
| Jun 30, 2025 | 154,366.00 |
| Mar 31, 2025 | 109,869.50 |
| Dec 31, 2024 | 92,956.50 |
| Sep 30, 2024 | 141,053.00 |
| Jun 30, 2024 | 278,292.00 |
| Mar 31, 2024 | 380,182.00 |
| Dec 31, 2023 | 891,662.00 |
| Sep 30, 2023 | 1.30 Mn |